Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 463

1.

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

Pujol JL, Lavole A, Quoix E, Molinier O, Souquet PJ, Barlesi F, Le Caer H, Moro-Sibilot D, Fournel P, Oster JP, Chatellain P, Barre P, Jeannin G, Mourlanette P, Derollez M, Herman D, Renault A, Dayen C, Lamy PJ, Langlais A, Morin F, Zalcman G; French Cooperative Thoracic Intergroup (IFCT); French Cooperative Thoracic Intergroup IFCT.

Ann Oncol. 2015 Feb 16. pii: mdv065. [Epub ahead of print]

PMID:
25688059
2.

Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?

Jacot W, Theillet C, Guiu S, Lamy PJ.

Future Oncol. 2015 Feb;11(4):557-9. doi: 10.2217/fon.14.268. No abstract available.

PMID:
25686112
3.

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

Reinert T, Schøler LV, Thomsen R, Tobiasen H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV, Stribolt K, Hamilton-Dutoit S, Nielsen HJ, Laurberg S, Pallisgaard N, Pedersen JS, Ørntoft TF, Andersen CL.

Gut. 2015 Feb 4. pii: gutjnl-2014-308859. doi: 10.1136/gutjnl-2014-308859. [Epub ahead of print]

PMID:
25654990
4.

Cometary science. Dust measurements in the coma of comet 67P/Churyumov-Gerasimenko inbound to the Sun.

Rotundi A, Sierks H, Della Corte V, Fulle M, Gutierrez PJ, Lara L, Barbieri C, Lamy PL, Rodrigo R, Koschny D, Rickman H, Keller HU, López-Moreno JJ, Accolla M, Agarwal J, A'Hearn MF, Altobelli N, Angrilli F, Barucci MA, Bertaux JL, Bertini I, Bodewits D, Bussoletti E, Colangeli L, Cosi M, Cremonese G, Crifo JF, Da Deppo V, Davidsson B, Debei S, De Cecco M, Esposito F, Ferrari M, Fornasier S, Giovane F, Gustafson B, Green SF, Groussin O, Grün E, Güttler C, Herranz ML, Hviid SF, Ip W, Ivanovski S, Jerónimo JM, Jorda L, Knollenberg J, Kramm R, Kührt E, Küppers M, Lazzarin M, Leese MR, López-Jiménez AC, Lucarelli F, Lowry SC, Marzari F, Epifani EM, McDonnell JA, Mennella V, Michalik H, Molina A, Morales R, Moreno F, Mottola S, Naletto G, Oklay N, Ortiz JL, Palomba E, Palumbo P, Perrin JM, Rodríguez J, Sabau L, Snodgrass C, Sordini R, Thomas N, Tubiana C, Vincent JB, Weissman P, Wenzel KP, Zakharov V, Zarnecki JC.

Science. 2015 Jan 23;347(6220):aaa3905. doi: 10.1126/science.aaa3905.

PMID:
25613898
5.

Cometary science. On the nucleus structure and activity of comet 67P/Churyumov-Gerasimenko.

Sierks H, Barbieri C, Lamy PL, Rodrigo R, Koschny D, Rickman H, Keller HU, Agarwal J, A'Hearn MF, Angrilli F, Auger AT, Barucci MA, Bertaux JL, Bertini I, Besse S, Bodewits D, Capanna C, Cremonese G, Da Deppo V, Davidsson B, Debei S, De Cecco M, Ferri F, Fornasier S, Fulle M, Gaskell R, Giacomini L, Groussin O, Gutierrez-Marques P, Gutiérrez PJ, Güttler C, Hoekzema N, Hviid SF, Ip WH, Jorda L, Knollenberg J, Kovacs G, Kramm JR, Kührt E, Küppers M, La Forgia F, Lara LM, Lazzarin M, Leyrat C, Lopez Moreno JJ, Magrin S, Marchi S, Marzari F, Massironi M, Michalik H, Moissl R, Mottola S, Naletto G, Oklay N, Pajola M, Pertile M, Preusker F, Sabau L, Scholten F, Snodgrass C, Thomas N, Tubiana C, Vincent JB, Wenzel KP, Zaccariotto M, Pätzold M.

Science. 2015 Jan 23;347(6220):aaa1044. doi: 10.1126/science.aaa1044.

PMID:
25613897
6.

Cometary science. The morphological diversity of comet 67P/Churyumov-Gerasimenko.

Thomas N, Sierks H, Barbieri C, Lamy PL, Rodrigo R, Rickman H, Koschny D, Keller HU, Agarwal J, A'Hearn MF, Angrilli F, Auger AT, Barucci MA, Bertaux JL, Bertini I, Besse S, Bodewits D, Cremonese G, Da Deppo V, Davidsson B, De Cecco M, Debei S, El-Maarry MR, Ferri F, Fornasier S, Fulle M, Giacomini L, Groussin O, Gutierrez PJ, Güttler C, Hviid SF, Ip WH, Jorda L, Knollenberg J, Kramm JR, Kührt E, Küppers M, La Forgia F, Lara LM, Lazzarin M, Lopez Moreno JJ, Magrin S, Marchi S, Marzari F, Massironi M, Michalik H, Moissl R, Mottola S, Naletto G, Oklay N, Pajola M, Pommerol A, Preusker F, Sabau L, Scholten F, Snodgrass C, Tubiana C, Vincent JB, Wenzel KP.

Science. 2015 Jan 23;347(6220):aaa0440. doi: 10.1126/science.aaa0440.

PMID:
25613893
7.

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].

Bellocq JP, Luporsi E, Barrière J, Bonastre J, Chetritt J, Le Corroller AG, de Crémoux P, Fina F, Gauchez AS, Kassab-Chahmi D, Lamy PJ, Martin PM, Mazouni C, Peyrat JP, Romieu G, Verdoni L, Mazeau-Woynar V.

Ann Pathol. 2014 Oct;34(5):349-51. doi: 10.1016/j.annpat.2014.04.010. Epub 2014 Aug 22. French.

PMID:
25439987
8.

Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties.

Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, Hendrix A, Lamy P, Dagnaes-Hansen F, Rasmussen MH, Bui KH, Fristrup N, Christensen EI, Nordentoft I, Morth JP, Jensen JB, Pedersen JS, Beck M, Theodorescu D, Borre M, Howard KA, Dyrskjøt L, Ørntoft TF.

Cancer Res. 2014 Oct 15;74(20):5758-71. doi: 10.1158/0008-5472.CAN-13-3512. Epub 2014 Sep 26.

PMID:
25261234
9.

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.

Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, Dagnaes-Hansen F, Øster B, Schepeler T, Tobiasen H, Thorsen K, Sieber OM, Gibbs P, Lamy P, Hansen TF, Jakobsen A, Riising EM, Helin K, Lubinski J, Hagemann-Madsen R, Laurberg S, Ørntoft TF, Andersen CL.

PLoS One. 2014 Jun 3;9(6):e96767. doi: 10.1371/journal.pone.0096767. eCollection 2014.

10.

Mutational context and diverse clonal development in early and late bladder cancer.

Nordentoft I, Lamy P, Birkenkamp-Demtröder K, Shumansky K, Vang S, Hornshøj H, Juul M, Villesen P, Hedegaard J, Roth A, Thorsen K, Høyer S, Borre M, Reinert T, Fristrup N, Dyrskjøt L, Shah S, Pedersen JS, Ørntoft TF.

Cell Rep. 2014 Jun 12;7(5):1649-63. doi: 10.1016/j.celrep.2014.04.038. Epub 2014 May 15.

11.

Iron homeostasis and anemia markers in early breast cancer.

Lamy PJ, Durigova A, Jacot W.

Clin Chim Acta. 2014 Jul 1;434:34-40. doi: 10.1016/j.cca.2014.04.011. Epub 2014 Apr 24. Review.

PMID:
24768787
12.

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F, Gillet B, Gongora C, Dechelotte P, Robert B, Del Rio M, Lamy PJ, Bibeau F, Nouaille M, Loriot V, Jarrousse AS, Molina F, Mathonnet M, Pezet D, Ychou M.

Nat Med. 2014 Apr;20(4):430-5. doi: 10.1038/nm.3511. Epub 2014 Mar 23.

PMID:
24658074
13.

Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.

Menegaux F, Anger A, Randrianasolo H, Mulot C, Laurent-Puig P, Iborra F, Bringer JP, Leizour B, Thuret R, Lamy PJ, Rébillard X, Trétarre B; EPICAP Study Group.

BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106.

14.

Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer.

Saadoun H, Lamy PJ, Thezenas S, Pouderoux S, Bibeau F, Montels F, Romieu G, Colombo PE, Gutowski M, Jacot W.

Future Oncol. 2014 Feb;10(2):195-209. doi: 10.2217/fon.13.177.

PMID:
24490606
15.

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer.

Jacot W, Thezenas S, Senal R, Viglianti C, Laberenne AC, Lopez-Crapez E, Bibeau F, Bleuse JP, Romieu G, Lamy PJ.

BMC Cancer. 2013 Nov 5;13:523. doi: 10.1186/1471-2407-13-523.

16.

[Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer].

Lamy PJ, Montels F, Tosi D, Leizour B, Bascoul-Mollevi C, Castan F, Roques S, Nielloud F, Rebillard X.

Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):537-44. doi: 10.1684/abc.2013.0894. French.

PMID:
24113439
17.

[Vitamin D and breast cancer: physiopathology, biological and clinical implications].

Firmin N, Lamy PJ, Romieu G, Jacot W.

Bull Cancer. 2014 Mar;101(3):266-82. doi: 10.1684/bdc.2013.1826. Review. French.

PMID:
24103818
18.

Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.

Maynadier M, Farnoud R, Lamy PJ, Laurent-Matha V, Garcia M, Rochefort H.

Int J Oncol. 2013 Nov;43(5):1683-90. doi: 10.3892/ijo.2013.2095. Epub 2013 Sep 10.

PMID:
24026424
19.

DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer.

Haldrup C, Mundbjerg K, Vestergaard EM, Lamy P, Wild P, Schulz WA, Arsov C, Visakorpi T, Borre M, Høyer S, Orntoft TF, Sørensen KD.

J Clin Oncol. 2013 Sep 10;31(26):3250-8. doi: 10.1200/JCO.2012.47.1847. Epub 2013 Aug 5.

20.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Jacquemier J, Spyratos F, Esterni B, Mozziconacci MJ, Antoine M, Arnould L, Lizard S, Bertheau P, Lehmann-Che J, Fournier CB, Krieger S, Bibeau F, Lamy PJ, Chenard MP, Legrain M, Guinebretière JM, Loussouarn D, Macgrogan G, Hostein I, Mathieu MC, Lacroix L, Valent A, Robin YM, Revillion F, Triki ML, Seaume A, Salomon AV, de Cremoux P, Portefaix G, Xerri L, Vacher S, Bièche I, Penault-Llorca F.

BMC Cancer. 2013 Jul 22;13:351. doi: 10.1186/1471-2407-13-351.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk